Benefit from reslizumab treatment in a patient with chronic spontaneous urticaria and cold urticaria

Chronic urticaria (CU) is a group of common and debilitating conditions containing both chronic spontaneous urticaria (CSU) and chronic inducible urticarias (CIndU) including cold urticaria (ColdU) [1]. While antihistamines and omalizumab are effective treatments for both CSU and ColdU [2], many patients show insufficient response to either or both of these treatments [3], and additional and better therapies are needed [4]. This article is protected by copyright. All rights reserved.

[1]  T. Zuberbier,et al.  Benefit of mepolizumab treatment in a patient with chronic spontaneous urticaria , 2018, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[2]  T. Jakob,et al.  Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence , 2017, The Journal of allergy and clinical immunology.

[3]  T. Zuberbier,et al.  Responsiveness and minimal important difference of the urticaria control test , 2017, The Journal of allergy and clinical immunology.

[4]  M. Maurer,et al.  Looking forward to new targeted treatments for chronic spontaneous urticaria , 2017, Clinical and Translational Allergy.

[5]  Ling Meng,et al.  Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials. , 2016, The Journal of allergy and clinical immunology.

[6]  A. Giménez-Arnau,et al.  Cross-Cultural Adaptation of the Urticaria Control Test From German to Castilian Spanish , 2015 .

[7]  Michihiro Hide,et al.  The EAACI/GA 2 LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update , 2015 .

[8]  H. Kita,et al.  Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin , 2014, The British journal of dermatology.

[9]  T. Zuberbier,et al.  The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. , 2014, Allergy.

[10]  T. Casale,et al.  Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control. , 2014, The Journal of allergy and clinical immunology.

[11]  T. Zuberbier,et al.  Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients , 2009, The British journal of dermatology.

[12]  W. Busse,et al.  Eosinophils in asthma. , 1992, Annals of allergy.